Oscar Health (NYSE:OSCR) Posts Quarterly Earnings Results, Beats Estimates By $0.34 EPS

Oscar Health (NYSE:OSCR) issued its quarterly earnings data on Tuesday. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.34, Briefing.com reports. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The firm had revenue of $2.14 billion during the quarter, compared to analysts’ expectations of $1.99 billion. During the same period in the prior year, the business posted ($0.18) EPS. The firm’s quarterly revenue was up 45.8% on a year-over-year basis.

Oscar Health Trading Up 4.6 %

Oscar Health stock traded up $0.90 during trading on Wednesday, reaching $20.67. 3,640,440 shares of the company were exchanged, compared to its average volume of 3,271,125. Oscar Health has a 52-week low of $4.72 and a 52-week high of $20.75. The company has a market capitalization of $4.75 billion, a P/E ratio of -16.67 and a beta of 1.66. The stock’s 50 day simple moving average is $15.41 and its two-hundred day simple moving average is $11.96. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19.

Analyst Upgrades and Downgrades

OSCR has been the topic of a number of recent analyst reports. Wells Fargo & Company upped their price target on Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. TheStreet upgraded Oscar Health from a “d” rating to a “c-” rating in a research note on Wednesday, February 21st. Raymond James began coverage on shares of Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target for the company. Finally, The Goldman Sachs Group boosted their price target on Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a report on Friday, February 9th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Oscar Health has an average rating of “Moderate Buy” and a consensus target price of $13.50.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.